OSE Immunotherapeutics SA develops immunotherapy products for cancer and auto-immune disease. Its clinical portfolio are developed under the brands of Tedopi, BI 765063, BiCKI, FR104, and OSE-127. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.
Industry:
Pharmaceuticals Major